Scalpel AI, a pioneer in surgical technology, has secured a £3.8m investment to enhance tool management in surgeries.
- Founded by two doctors, Scalpel AI addresses critical errors in surgical tool management through AI and computer vision.
- The company’s digital twin technology ensures accurate tracking and verification of surgical instruments and trays.
- Support from notable investors like Mercia Ventures highlights Scalpel AI’s potential to influence the healthcare industry.
- The startup’s innovative solutions aim to make surgeries safer and more efficient, paving the way for personalised healthcare.
Scalpel AI, an Essex-based startup, recently closed a successful £3.8m funding round aimed at revolutionising surgical tool management. Established in 2017 by two doctors who witnessed first-hand the impact of tool mismanagement, the company’s mission is to enhance surgical safety and efficiency.
Utilising advanced AI and computer vision, Scalpel AI’s technology creates digital replicas of surgical equipment. These digital twins are carefully analysed to ensure accurate tracking of instruments’ performance, thus reducing common errors. According to co-founder and CEO Dr Yeshwanth Pulijala, the technology not only supports operations within the theatre but also contributes to more streamlined processes behind the scenes.
In tackling initial technological integration challenges, Scalpel AI has closely collaborated with end-users to tailor solutions to their needs. Dr Shahnawaz Ahmed, the company’s chief technology officer, emphasises the impact of their proprietary algorithms in eliminating supply chain errors and reducing handling times, reinforcing the system’s reliability in surgical settings.
Through its most recent funding round, led by Mercia Ventures with participation from Tensor Ventures, Scalpel AI plans to scale its operations internationally. Mercia Ventures’ representative, Lee Lindley, notes that existing methods like barcodes and RFID tags lack Scalpel AI’s sophistication, suggesting the platform’s potential to become a global industry standard.
Having previously benefited from government grants via Innovate UK, Scalpel AI is well-positioned to extend its market reach. This funding not only signals confidence from the investment community but also underscores the innovative strides the company is making toward a safer and more efficient healthcare environment.
Scalpel AI’s recent investment marks a significant step towards enhancing surgical safety and efficiency on a global scale.
